Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
一项开放标签、随机、对照适应性平台试验（PLATCOV）研究了早期 COVID-19 患者使用高剂量伊维菌素的药代动力学。
期刊:Elife
影响因子:6.4
doi:10.7554/eLife.83201
Schilling, William H K; Jittamala, Podjanee; Watson, James A; Ekkapongpisit, Maneerat; Siripoon, Tanaya; Ngamprasertchai, Thundon; Luvira, Viravarn; Pongwilai, Sasithorn; Cruz, Cintia; Callery, James J; Boyd, Simon; Kruabkontho, Varaporn; Ngernseng, Thatsanun; Tubprasert, Jaruwan; Abdad, Mohammad Yazid; Piaraksa, Nattaporn; Suwannasin, Kanokon; Hanboonkunupakarn, Pongtorn; Hanboonkunupakarn, Borimas; Sookprome, Sakol; Poovorawan, Kittiyod; Thaipadungpanit, Janjira; Blacksell, Stuart; Imwong, Mallika; Tarning, Joel; Taylor, Walter R J; Chotivanich, Vasin; Sangketchon, Chunlanee; Ruksakul, Wiroj; Chotivanich, Kesinee; Teixeira, Mauro Martins; Pukrittayakamee, Sasithon; Dondorp, Arjen M; Day, Nicholas P J; Piyaphanee, Watcharapong; Phumratanaprapin, Weerapong; White, Nicholas J
